Stockreport

Vaccinex to Present at the Ladenburg Thalmann 2019 Healthcare Conference

VACCINEX INC  (VCNX) 
PDF ROCHESTER, N.Y., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering novel investigational antibody the [Read more]